Delivery Order SPE2DB24D2205-SPE2DB24FDSQC
- Not listed
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,611.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical program. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract valued at $12,499.98, without any set-aside designation....
- This federal contract award is for the delivery of 4,558,549,115 units of Cyclosporine 0.05% eye emulsion in 60-count packages. The $27,929.37 firm fixed price contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. AmerisourceBergen is a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,082.76 and a performance period through March 19, 2024. The contract does not have a set-aside designation....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm-fixed-price delivery order. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $9,057.01. The contract has an ultimate completion date of October 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to support Defense Logistics Agency (DLA) Troop Support Medical operations. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The award, valued at $6,320.92, is a firm-fixed price delivery order contract with a completion date of January 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,430.12 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion 60s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $4,114.03 on May 6, 2025. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSQCDelivery Order
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $28,455.22 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.5k | 4/12/24 |